We are live on ! Find out more
CLYM

Climb Bio
CLYM

32 hedge funds and large institutions have $311M invested in Climb Bio in 2021 Q3 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

65.08% more ownership

Funds ownership: 0% → 65.08% (+65%)

Holders
32
Holders Change
+32
Holders Change %
–
% of All Funds
0.56%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
32
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$272M
2
SC
Samlyn Capital
New York
+$34.7M
3
WP
Woodline Partners
California
+$8M
4
BlackRock
BlackRock
New York
+$6.86M
5
MIM
Monashee Investment Management
Massachusetts
+$6.31M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$236M +$272M +13,150,849 New
SC
2
Samlyn Capital
New York
$30.2M +$34.7M +1,681,025 New
WP
3
Woodline Partners
California
$6.96M +$8M +387,224 New
BlackRock
4
BlackRock
New York
$5.97M +$6.86M +332,126 New
MIM
5
Monashee Investment Management
Massachusetts
$5.49M +$6.31M +305,233 New
Tudor Investment Corp
6
Tudor Investment Corp
Connecticut
$5.17M +$5.94M +287,294 New
JP Morgan Chase
7
JP Morgan Chase
New York
$3.66M +$4.2M +203,438 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$3.59M +$4.12M +199,594 New
Goldman Sachs
9
Goldman Sachs
New York
$2.98M +$3.43M +165,952 New
Hudson Bay Capital Management
10
Hudson Bay Capital Management
Connecticut
$1.8M +$2.07M +100,000 New
State Street
11
State Street
Massachusetts
$1.55M +$1.78M +86,101 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.38M +$1.59M +76,904 New
CCM
13
CAAS Capital Management
New York
$1.35M +$1.55M +75,000 New
Millennium Management
14
Millennium Management
New York
$1.29M +$1.49M +71,983 New
Northern Trust
15
Northern Trust
Illinois
$1.12M +$1.28M +62,036 New
Charles Schwab
16
Charles Schwab
California
$310K +$356K +17,224 New
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$268K +$308K +14,912 New
UBS Group
18
UBS Group
Switzerland
$249K +$287K +13,873 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$237K +$273K +13,208 New
HF
20
HRT Financial
New York
$212K +$244K +11,797 New
Morgan Stanley
21
Morgan Stanley
New York
$110K +$126K +6,113 New
Deutsche Bank
22
Deutsche Bank
Germany
$73K +$83.9K +4,063 New
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$69K +$78.8K +3,813 New
AIG
24
American International Group
New York
$69K +$79.8K +3,863 New
SO
25
STRS Ohio
Ohio
$28K +$33.1K +1,600 New
1
2

CLYM Hedge Fund Activity: Q3 2021 in Review

32 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Climb Bio (CLYM) for Q3 2021, worth a combined $311M.

Buyers outnumbered sellers: 32 funds opened new CLYM positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $272M.

  • 32 institutional investors held Climb Bio (CLYM) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $311M of Climb Bio stock for Q3 2021.
  • 32 funds opened new Climb Bio positions in Q3 2021 and 0 closed out, a net change of +32 holders.
  • The largest Climb Bio buyer in Q3 2021 was RA Capital Management, an estimated $272M added.

Based on aggregated 13F filings for Q3 2021.